Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
about
Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J miceDo we now have a relevant animal model for breast cancer?Proteasome inhibitors: their effects on arachidonic acid release from cells in culture and arachidonic acid metabolism in rat liver cellsTetrandrine and thapsigargin release arachidonic acid from cells in culture and stimulate prostacyclin production in rat liver cells, but may do so by different pathways.Understanding phenotypic variation in rodent models with germline Apc mutationsPhospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic interventionGenetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer riskDeficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ miceNotum is required for neural and head induction via Wnt deacylation, oxidation, and inactivationThe genetic background modifies the spontaneous and X-ray-induced tumor spectrum in the Apc1638N mouse modelTumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiersTumor burden and clonality in multiple intestinal neoplasia mouse/normal mouse aggregation chimerasAlpha-catenin is essential in intestinal adenoma formationMlh1 deficiency enhances several phenotypes of Apc(Min)/+ miceDeletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesisOn the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymesGenetic architecture of a morphological shape difference between two Drosophila speciesThe genetic basis of breast cancer and its clinical implications.A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice.Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract.A strategy to identify dominant point mutant modifiers of a quantitative trait.Stem cells: the intestinal stem cell as a paradigm.Genetic basis of variation in adenoma multiplicity in ApcMin/+ Mom1S mice.A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice.Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibilityHuman cancer xenografts in outbred nude mice can be confounded by polymorphisms in a modifier of tumorigenesisMultiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic miceModifier genes and the plasticity of genetic networks in mice.Smad7 dependent expression signature highlights BMP2 and HK2 signaling in HSC transdifferentiation.Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis.hairy: A quantitative trait locus for drosophila sensory bristle number.Identification of quantitative trait loci influencing wood property traits in loblolly pine (Pinus taeda L.). III. QTL Verification and candidate gene mapping.Understanding the human condition: experimental strategies in mammalian genetics.Modeling cancer in mice.Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patientsA Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesisIdentification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice
P2860
Q24795737-4FFF9DB7-8DAF-4BB0-8DBA-96B0449AEBCEQ24800439-66E63478-7350-4F5D-9061-6178C945D19BQ24801210-3FDB4697-04B0-4240-B850-A3A9C2A1A0ACQ24814415-C95334C2-2F30-48DF-A35B-E03716CA2414Q26824920-0228EEF1-7CC6-4165-B7C1-DEF9A7A17355Q26997377-D9C9A99E-ABF6-46A2-8FBE-A97F688E2AB6Q28396100-EB6F4029-D6B7-4CC6-8E5F-0D227566BD76Q28505216-B344895B-F101-4C19-80D7-16E70BF07CDEQ28505847-9A70D3CB-219F-4EF1-801A-F340A335BA21Q28506414-3BFEF893-B59C-4E49-B9BB-63FC808043F4Q28507960-FE4034D9-CF50-455C-ABD4-55B8C61753CAQ28511450-B8B97295-9596-4185-8771-CDC5D978DFD5Q28585041-894C7DA8-EF3A-44DF-A7B2-85EAF97D38DDQ28588324-436E9FA4-22AD-409D-AA84-363931065ADEQ28590770-AEB33B12-3DBE-4D17-9754-E873CFE83EEDQ28592582-19C75E2B-6785-48A0-8583-9DDF9323F319Q28769091-BB684C7D-B89F-4EDC-9B18-D77EC0DE6FDEQ33536033-51BE1FE3-3B92-4416-A151-37BC6CF37029Q33556956-2B354998-ACEC-4998-936F-CE2C07AD4CE6Q33565825-EA65B6E2-E4A9-4D27-B991-FFD34C57422EQ33711292-E4BDE301-5859-4104-AC75-B6881B364361Q33784960-9AD29EE4-3A85-44AF-914D-B1E65E8A1120Q33846215-8D525F38-1C63-48A6-8CD1-4F081B17633BQ33863400-9E66450B-EB14-4DCB-974E-43C6CA45BE70Q33950098-AF5C586C-1ED1-468C-85C0-ACB5FC7343B7Q33975178-379BD219-32D9-488E-A1B4-A673BFE35F70Q34016630-12F3F047-CD39-4214-9F1F-B8181A000435Q34037996-0F35D5E0-B512-4E0A-830C-87B1235720AFQ34236664-E0395EA8-7CC5-442C-9A26-00C3EDABA557Q34284758-AC21D59E-510D-413D-96A3-9DF7B2594479Q34343218-F0F2F513-D6DB-475B-9A68-949114B893C3Q34415813-0D919077-BA2A-413E-85D0-CAD6CC76A2D7Q34615856-5127B16D-8137-4CF5-A902-39B1A0F6459AQ34618093-63416A1A-D175-4BAA-8C0F-90A11440AA9BQ34726732-87FEBE51-1C7C-4D92-BE4F-E346C7295380Q34770630-557142C6-E02C-4505-80BB-5652A11DA84CQ34786068-7527C052-E22D-430E-A586-DE73DFA4CE59Q34804602-5FCDA71B-43DB-4203-9DBB-0C076DB40359Q35003070-FF0EADE7-9795-4212-B5F7-56663F7B3B15Q35034369-D847EA23-1C5E-42A8-9C37-DFEFFF720404
P2860
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
description
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
articolo scientifico
@it
artículu científicu espublizáu en 1997
@ast
im September 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/09/01)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/09/01)
@nl
наукова стаття, опублікована у вересні 1997
@uk
name
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
@ast
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
@en
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
@nl
type
label
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
@ast
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
@en
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
@nl
prefLabel
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
@ast
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
@en
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
@nl
P2093
P2860
P356
P1433
P1476
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
@en
P2093
E. S. Lander
K. H. Hong
P. Richardson
R. B. Halberg
R. Mulherkar
R. T. Cormier
T. L. Hawkins
W. F. Dove
P2860
P2888
P356
10.1038/NG0997-88
P407
P577
1997-09-01T00:00:00Z